Repligen Corp (RGEN)

Date: O: H: L: C: Vol:

Finanzdaten der Repligen Corp-Aktie (RGEN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.54%209.31	204.13	194.26	197.91	188.81
Cost Of Revenue	4.50%98.33	94.09	85.97	94.08	88.29
	9.10%83.59	76.62	76.54	-	-
Selling, General, and Administrative	9.10%83.59	76.62	76.54	-	-
Research and Development	0.12%14.44	14.42	14.46	-	-
Costs And Expenses	25.62%238.86	190.15	178.32	180.05	171.98
Depreciation and Amortization	0.33%19.12	19.06	19.76	19.95	20.01
Operating Income/Loss	311.41%-29.55	13.98	15.94	17.87	16.83
Nonoperating Income/Loss	1,447%2.74	0.18	-14.17	1.25	0.29
Income/Loss From Continuing Operations Before Tax	289.42%-26.81	14.15	1.77	19.11	17.11
Income Tax Expense/Benefit, Deferred	30.97%3.83	2.93	-7.70	2.41	-3.22
Income Tax Expense/Benefit	27.11%11.62	9.15	-6.56	5.83	2.20
	867.41%-38.43	5.01	8.33	13.29	14.91
Attributable To Parent	867.41%-38.43	5.01	8.33	13.29	14.91
Basic Average Shares	0.25%56.56	56.42	56.35	0.00	0.06
Diluted Average Shares	0.14%56.56	56.64	56.67	0.00	0.06
Basic Earnings Per Share	855.56%-0.68	0.09	0.15	0.24	0.27
Diluted Earnings Per Share	855.56%-0.68	0.09	0.15	0.23	0.26